Patients could soon access higher-dose injections.Shares of Novo Nordisk (NVO +3.42%) are gaining on Monday, up 3.5% as of 2:40 p.m. ET. The jump comes as the S&P 500 and the Nasdaq Composite gained 0.8% and 0.9%, respectively. The Danish drugmaker submitted an application today seeking regulatory approval for a higher dose of its blockbuster weight-loss drug, Wegovy.NYSE : NVONovo NordiskToday's Change( 3.42 %) $1.61Current Price$ 48.67Key Data PointsMarket Cap$159BDay's Range$ 48.19 - $49.0252wk Range$ ...